Digital therapies

with clinically

proven efficacy

Orexo´s digital therapies deliver therapeutic interventions to patients to prevent, manage, or treat a medical disorder or disease. The therapies are available for patients in their own privacy 24/7 and can be used as a standalone treatment or together with traditional drugs. Its efficacy has been demonstrated in numerous published clinical trials including thousands of patients.

The therapies are developed based on established cognitive-behavioral therapy technique which is a goal-oriented psychotherapy treatment that takes a hands-on, practical approach to problem-solving. The aim is to provide support and change patterns of thinking or behavior that are behind patients difficulties.

Pipeline of Digital Therapies 

Digital Therapies
Technical development
Approved and/or Launched
deprexis® Depression
Partner: GAIA AG
vorvida® Alcohol misuse, incl. alcohol use disorder
Partner: GAIA AG
OXD01 Opioidaddiction
Partner: GAIA AG
World-leading technology

World-leading technology

Our digital therapies are fully automated developed by GAIA and based on its proprietary artificial intelligence (AI)-expert system, broca®.

deprexis® - one of the most clinically tested digital therapies

deprexis® - one of the most clinically tested digital therapies

deprexis® effectiveness in managing the symptoms of depression has been evaluated and published in 11 randomized clinical trials (RCTs) including more than 2,800 patients.